S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company

Evaxion Biotech A/S (EVAX) Institutional Ownership

$0.69
+0.01 (+1.46%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.62
▼
$0.69
50-Day Range
$0.62
▼
$1.17
52-Week Range
$0.47
▼
$2.28
Volume
41,768 shs
Average Volume
113,488 shs
Market Capitalization
$19.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Evaxion Biotech A/S (NASDAQ:EVAX)

Current
Institutional Ownership
Percentage
0.58%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$236,133.90
Number of
Institutional Sellers
(last 12 months)
0
Get EVAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evaxion Biotech A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

EVAX Institutional Buying and Selling by Quarter


Evaxion Biotech A/S Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/11/2023AE Wealth Management LLC48,633$41K0.0%N/A0.176%
8/11/2023JPMorgan Chase & Co.29,154$38K0.0%N/A0.113%
5/16/2023Susquehanna International Group LLP118,722$0.13M0.0%+185.4%0.470%
5/12/2023Moloney Securities Asset Management LLC36,000$41K0.0%N/A0.142%
2/14/2023Pura Vida Investments LLC16,842$30K0.0%N/A0.071%
11/17/2022Telemetry Investments L.L.C.29,000$76K0.1%-76.2%0.122%
5/13/2022Luminus Management LLC424,527$1.29M0.3%-45.4%1.830%
11/16/2021Telemetry Investments L.L.C.30,743$0.30M0.4%-26.3%0.160%
11/12/2021Credit Suisse AG40,315$0.39M0.0%N/A0.210%
8/16/2021Maven Securities LTD235,606$1.76M0.1%+2.2%1.227%
8/16/2021Telemetry Investments L.L.C.41,729$0.32M0.4%-43.5%0.217%
5/18/2021Luminus Management LLC194,929$1.15M0.2%N/A1.015%
5/18/2021Alyeska Investment Group L.P.86,726$0.51M0.0%N/A0.452%
5/13/2021Kepos Capital LP37,098$0.22M0.0%N/A0.193%
5/12/2021Granite Point Capital Management L.P.224,601$1.33M0.0%N/A1.170%
(Data available from 1/1/2016 forward)













EVAX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of EVAX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Evaxion Biotech A/S shares: Luminus Management LLC ($1.29M), Susquehanna International Group LLP ($0.13M), Telemetry Investments L.L.C. ($76K), AE Wealth Management LLC ($41K), Moloney Securities Asset Management LLC ($41K), and JPMorgan Chase & Co. ($38K), and Pura Vida Investments LLC ($30K).Learn more on EVAX's institutional investors.

What percentage of Evaxion Biotech A/S stock is owned by institutional investors?

0.58% of Evaxion Biotech A/S stock is owned by institutional investors. Learn more on EVAX's institutional investor holdings.

Which institutional investors have been buying Evaxion Biotech A/S stock?

The following institutional investors have purchased Evaxion Biotech A/S stock in the last 24 months: Susquehanna International Group LLP ($77.12K), AE Wealth Management LLC ($48.63K), Moloney Securities Asset Management LLC ($36K), JPMorgan Chase & Co. ($29.15K), and Pura Vida Investments LLC ($16.84K).

How much institutional buying is happening at Evaxion Biotech A/S?

Institutional investors have bought a total of 207,751 shares in the last 24 months. This purchase volume represents approximately $0.24M in transactions.

Which Evaxion Biotech A/S major shareholders have been selling company stock?

The following institutional investors have sold Evaxion Biotech A/S stock in the last 24 months: Luminus Management LLC ($0.35M), and Telemetry Investments L.L.C. ($93K).

How much institutional selling is happening at Evaxion Biotech A/S?

Institutional investors have sold a total of 446,463 shares in the last 24 months. This volume of shares sold represents approximately $1.32M in transactions.


Related Companies:
This page (NASDAQ:EVAX) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -